Acetaldehyde lyase with thermal stability and substrate tolerance and application of acetaldehyde lyase
By performing multi-point mutation and iterative construction of acetaldehyde lyase, its thermal stability and substrate tolerance are improved, the problem of low catalytic efficiency in the existing technology is solved, and high efficiency under high temperature and high concentration conditions are achieved Acetaldehyde conversion.
Patent Information
- Application Number
- CN202410967264.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-08
AI Technical Summary
The existing acetaldehyde lyase has not yet met the requirements of industrial production in terms of thermal stability and substrate tolerance, especially the problem of low catalytic efficiency under high temperature and high concentration acetaldehyde conditions.
Iterative mutants were constructed to improve the thermal stability and substrate tolerance of the enzyme by performing multi-point mutations, including mutation sites M133L, A134K, E500R, R89Y, A148I, L182M, etc. and optimize the interface structure of the enzyme by combining mutants to improve catalytic efficiency.
The thermal stability and substrate tolerance of acetaldehyde lyase were significantly improved. The half-life of iterative mutant M13 reached 36.3 hours, the catalytic efficiency and conversion rate were significantly improved. The conversion rate reached 82.34% when the acetaldehyde concentration was 2.5M. Much more than 8% of the initial mutant.
Smart Images

Figure CN118910025A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of gene engineering and enzyme engineering, and in particular to an acetaldehyde lyase with thermal stability and substrate tolerance and an application thereof. Background Art
[0002] Acetoin is a platform compound widely used in the pharmaceutical, chemical, food, cosmetics and other industries. There are two methods for the synthesis of acetoin: chemical synthesis and biosynthesis. At present, the acetoin on the market is mainly synthesized by chemical synthesis, but the chemical method has problems such as harsh reaction conditions, low conversion rate, many by-products and unfriendly environment. In recent years, the biological synthesis of acetoin has attracted the attention of researchers due to its advantages such as mild reaction, wide source of raw materials and high conversion rate. The biosynthesis of acetoin is divided into microbial fermentation and enzyme catalysis. Through metabolic engineering to construct efficient engineered bacteria and establish efficient fermentation strategies, microbial fermentation has achieved high yield of acetoin, but due to the high cost of separation of fermentation raw materials and products, the cost is still a certain distance from industrialization. The enzyme catalysis method (including whole cell and pure enzyme catalysis) uses 2,3-butanediol, pyruvate and diacetyl as substrates, and does not have a competitive advantage in substrate cost or conversion rate. Therefore, the development of cheap substrates and high catalytic enzymes for the synthesis of acetoin is of great value for its industrialization.
[0003] An acetaldehyde lyase (ALS) that uses acetaldehyde as a substrate to synthesize acetoin has been developed. A mutant ALS-I28V / L482E with higher catalytic efficiency and substrate tolerance has been obtained by semi-rational modification of the catalytic active center and key residues of the substrate channel of the enzyme. However, the mutant still cannot meet the requirements of industrial production in terms of thermal stability and substrate tolerance. Therefore, how to further improve the thermal stability and substrate tolerance of acetaldehyde lyase is an urgent problem to be solved. Summary of the invention
[0004] In order to solve the above-mentioned deficiencies in the prior art, the object of the present invention is to provide an acetaldehyde lyase with thermal stability and substrate tolerance and its application, wherein the acetaldehyde lyase has better thermal stability and substrate tolerance.
[0005] The technical solution of the present invention to solve the above technical problems is as follows: provide an acetaldehyde lyase with thermal stability and substrate tolerance, wherein the acetaldehyde lyase ALS-I28V / L482E is subjected to the following mutations:
[0006] The mutation site is M133L; or
[0007] The mutation site is A134K; or
[0008] The mutation site is E500R; or
[0009] The mutation site is R89Y; or
[0010] The mutation site is A148I; or
[0011] The mutation site is A148V; or
[0012] The mutation site is L182I; or
[0013] The mutation site is L182M; or
[0014] Iterative mutation M2: combined mutation of E500R and R89Y mutation sites; or
[0015] Iterative mutation M4: combined mutation of A148I and V181S mutation sites; or
[0016] Iterative mutation M5: combined mutation of E500R, R89Y and S503I mutation sites; or
[0017] Iterative mutation M6: combined mutation of A148I, V181S and L182M mutation sites; or
[0018] Iterative mutation M9: A148I, V181S, L182M and H185R mutation site combination mutation; or
[0019] Iterative mutation M10: combined mutation of A148I, V181S and H185R mutation sites; or
[0020] Iterative mutation M11: E500R, R89Y, S503I, A148I, V181S, L182M and H185R mutation site combination mutation; or
[0021] Iterative mutation M12: A134K, A148I, V181S, L182M and H185R mutation site combination mutation; or
[0022] Iterative mutation M13: combined mutations of E500R, R89Y, S503I, A134K, A148I, V181S, L182M and H185R mutation sites.
[0023] The application of the acetaldehyde lyase with thermal stability and substrate tolerance provided above in catalyzing the preparation of acetoin from acetaldehyde.
[0024] The method for preparing acetoin by catalyzing acetaldehyde with the above-mentioned acetaldehyde lyase having thermal stability and substrate tolerance comprises the following steps:
[0025] Acetaldehyde lyase and a buffer are added to acetaldehyde to carry out a catalytic reaction to prepare acetoin.
[0026] Further, the acetaldehyde concentration is 1-2.5M.
[0027] Further, the molar ratio of acetaldehyde to acetaldehyde lyase is 1:3-8×10 -6 .
[0028] Furthermore, the temperature during the reaction is 30-60° C. and the reaction time is 1-4 h.
[0029] Furthermore, a buffer solution is added to the reaction system, and the pH of the buffer solution is 6-8.
[0030] Furthermore, the reaction system also includes a coenzyme at a concentration of 0.15-0.25 mM; preferably, the coenzyme is TPP at a concentration of 0.2 mM.
[0031] Furthermore, the reaction system also includes metal ions, and the metal ion concentration is 1.5-2.5 mM; preferably, the metal ion is Mg 2+ , concentration is 2mM.
[0032] The present invention has the following beneficial effects:
[0033] The present invention uses the mutant ALS-I28V / L482E of acetaldehyde lyase as the initial mutant M1, performs saturation mutation on the above hot spot amino acid residues, and obtains 15 beneficial mutations through screening and sequencing, namely M133L, A134K, D193M, L182M, L182I, S183P, E500R, S503I, D39K, R89W, R89Y, A148V, A148I, V181S, and H185R. Subsequently, the 15 mutants are purified, and the initial enzyme M1 is used as a control to determine the enzymatic properties and enzyme kinetic parameters of each mutant. The results showed that the optimal reaction temperature of M133L, A134K and E500R mutants reached 45℃, which was 15℃ higher than the optimal reaction temperature of M1 at 30℃; the half-life of E500R mutant was increased to 18.3h, which was 2.44 times higher than the 7.5h of M1; the V max The value increased to 26.95 U / mg, which was 4.99 times higher than that of M1 (5.40 U / mg); the K cat / K m The value increased the most, reaching 87.55s -1 ·M -1 , compared with M1's 23.33s -1 ·M -1 The above results show that the catalytic efficiency and thermal stability of ALS enzyme can be effectively improved by strengthening the subunit interface.
[0034] In order to further improve the performance of enzyme mutants, the above beneficial mutants were combined for iterative mutation to construct multi-site mutants. Iterative mutation was performed independently according to three interfaces. After obtaining beneficial multi-point mutations, three interface combination mutations were performed to finally determine the best multi-site mutant. After multiple rounds of iterative mutation, an 8-site iterative mutant M13 with improved thermal stability and tolerance was finally obtained. Its mutation sites were A148I, V181S, L182M, H185R, E500R, R89Y, S503I, and A134K, respectively. The half-life reached 36.3h, which was 4.84 times higher than that of M1; its V max and K cat / K m The values reached 78.07U / mg and 287.38s -1 ·M -1 , which were 8.7 times and 12.3 times higher than M1, respectively. When the acetaldehyde concentration was 2.5M, the conversion rate after 6h of reaction reached 82.34%, while the conversion rate of M1 at this concentration was only 8.00%. In addition, during the iterative mutation process, an iterative mutant M4 with the highest acetaldehyde tolerance was obtained. When the acetaldehyde concentration was 2.5M, the conversion rate after 6h of reaction could reach 100%, but its thermal stability and catalytic efficiency were lower than those of M13.
[0035] In order to investigate the industrial performance of the obtained acetaldehyde lyase mutants, the initial mutant M1, the fusion protein ELP-M1, the iterative mutant M4 and the iterative mutant M13 were subjected to batch feeding reaction to investigate the production of acetoin under high concentration acetaldehyde conditions. Under the batch feeding conditions, the acetoin production of the initial mutant M1 reached 60.67 g / L, and the acetoin production of the fusion protein ELP-M1 reached 95.75 g / L, which was 57.8% higher than that of the initial mutant M1, while the acetoin production of the iterative mutants M4 and M13 reached 158.02 g / L and 187.59 g / L, respectively, which were 2.60 times and 3.09 times that of the initial mutant M1. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 The optimum temperature of the beneficial mutant enzyme in Example 1 is determined.
[0037] Figure 2 This is the thermostability curve of the beneficial mutant enzyme in Example 1.
[0038] Figure 3 The half-life test results of the beneficial mutants in Example 1 are shown in FIG.
[0039] Figure 4 The following are the results of the test on the tolerance of the beneficial mutant enzyme to acetaldehyde in Example 1.
[0040] Figure 5is the Michaelis-Menten equation for the enzyme kinetics of the beneficial mutant in Example 1.
[0041] Figure 6 This is the result of the optimal temperature determination of the mutant enzyme in the first iteration in Example 2.
[0042] Figure 7 This is the thermal stability curve of the mutant enzyme in the first iteration in Example 2.
[0043] Figure 8 This is the half-life test result of the first iteration mutant in Example 2.
[0044] Fig. 9 This is the enzyme kinetics Michaelis-Menten equation of the first iteration mutant in Example 2.
[0045] Fig.10 This is the result of the first iteration mutant enzyme tolerance test to acetaldehyde in Example 2.
[0046] Fig.11 The optimum temperature and thermal stability curve of the second iteration mutant enzyme in Example 3 are measured.
[0047] Fig.12 This is the half-life test result of the second iteration mutant in Example 3.
[0048] Fig.13 This is the second iteration of the mutant enzyme kinetics Michaelis-Menten equation in Example 3.
[0049] Fig.14 This is the result of the second iteration mutant enzyme tolerance test to acetaldehyde in Example 3.
[0050] Fig.15 The optimum temperature and thermal stability curve of the third iteration mutant enzyme in Example 4 are measured.
[0051] Fig.16 This is the half-life test result of the third iteration mutant in Example 4.
[0052] Fig.17 This is the third iteration of the mutant enzyme kinetics Michaelis-Menten equation in Example 4.
[0053] Fig.18 This is the result of the third iteration mutant enzyme tolerance test to acetaldehyde in Example 4.
[0054] Fig.19 The optimum temperature and thermal stability curves of iterative mutants of the three interface combinations in Example 5 are determined.
[0055] Fig. 20 The results of the iterative mutant half-life tests of the three interface combinations in Example 5 are shown.
[0056] Fig.21 This is the Michaelis-Menten equation for the iterative mutant enzyme kinetics of the three interface combinations in Example 5.
[0057] Fig. 22 The results of the acetaldehyde tolerance test of the iterative mutant enzymes with three interface combinations in Example 5 are shown.
[0058] Fig.23 The results of fed-batch reaction; A is the initial mutant M1; B is the fusion protein ELP-M1; C is the iterative mutant M4; D is the iterative mutant M13; the solid line is the change in the amount of acetoin generated, and the dotted line is the change in the acetaldehyde content. DETAILED DESCRIPTION
[0059] The following examples are only used to explain the present invention and are not intended to limit the scope of the present invention. If no specific conditions are specified in the examples, the conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0060] Example 1: Single point mutation
[0061] The present invention uses the acetaldehyde lyase ALS (ALS-I28V / L482E) recorded in the application number 202211560186.7 and the invention name "An acetaldehyde lyase, acetaldehyde lyase fusion protein and its preparation method and application" as the initial mutant M1, and performs single-point mutation on it to form the following beneficial mutants, and the construction of each mutant strain, crude enzyme or enzyme purification process are all carried out with reference to the above patent document. The mutation sites for single-point mutation in the present invention are specifically:
[0062] Aspartic acid at position 39 mutated to lysine, i.e. the mutation site was D39K;
[0063] The arginine at position 89 mutated to tryptophan, i.e. the mutation site was R89W;
[0064] The arginine at position 89 mutated to tyrosine, i.e. the mutation site was R89Y;
[0065] The methionine at position 133 mutated to leucine, i.e. the mutation site was M133L;
[0066] Alanine at position 134 mutated to lysine, i.e. the mutation site is A134K;
[0067] Alanine at position 148 mutated to isoleucine, i.e. the mutation site is A148I;
[0068] Alanine at position 148 mutated to valine, i.e. the mutation site is A148V;
[0069] The valine at position 181 mutated to serine, i.e. the mutation site was V181S;
[0070] Leucine at position 182 mutates to isoleucine, i.e. the mutation site is L182I;
[0071] Leucine at position 182 mutated to methionine, i.e. the mutation site was L182M;
[0072] The serine at position 183 mutated to proline, i.e. the mutation site was S183P;
[0073] The histidine at position 185 mutated to arginine, i.e. the mutation site was H185R;
[0074] Aspartic acid at position 193 mutated to methionine, i.e. the mutation site was D193M;
[0075] The 500th glutamic acid mutated to arginine, i.e. the mutation site was E500R;
[0076] The serine at position 503 mutated to isoleucine, that is, the mutation site was S503I.
[0077] The enzymatic properties and kinetic parameters of the above mutants were determined as follows:
[0078] 1. Determination of optimum temperature
[0079] In 50 mM PBS pH 8.0 buffer, 100 mM acetaldehyde was used as substrate, 0.1 mM coenzyme TPP, 1 mM Mg 2+ , 30 μg of M1 and each mutant enzyme were added respectively, PBS buffer with pH 8 was added, the reaction volume was 0.5 mL, and the reactions were carried out at 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, and 55°C for 1 h, and the production of acetoin was determined by VP colorimetric reaction.
[0080] Enzyme activity unit definition: the amount of protein required to generate 1mM acetoin per minute. The highest enzyme activity value is defined as 100%, and the relative enzyme activity at that temperature is calculated. The results are shown in Figure 1 .
[0081] Depend on Figure 1 It can be seen that the optimum temperature of M1 is 30°C, while the optimum temperatures of the beneficial mutants have all increased by 5 to 15°C, among which M133L, A134K and E500R have the largest increase, with the optimum temperature reaching 15°C. In addition, compared with M1, some beneficial mutants not only have an increased optimum temperature, but also have an increased enzyme activity in the catalytic reaction. Among them, the enzyme activity of the E500R mutant has increased the most, reaching 7.34U / mg, which is 3.1 times that of M1.
[0082] 2. Determination of half-life
[0083] Take an appropriate amount of pure enzyme and dilute it to 1 mg / mL. Incubate it at 30°C, take samples at different time points, and measure the enzyme activity of the pure enzyme after incubation. The time point gradient is set to 1, 2, 3, 4, and 6 h. The initial enzyme activity value before incubation is defined as 100%. Calculate the residual enzyme activity at that temperature and draw a curve of the residual enzyme activity changing with temperature.
[0084] According to the one-step inactivation model of the enzyme:
[0085]
[0086] In the formula, E is an active enzyme; D is an inactivated enzyme; k d is the deactivation reaction rate constant.
[0087] When the inactivation of an enzyme follows first-order kinetics, then:
[0088] LqCy p =lnA0 - k d t (1)
[0089] Among them, A r =A p / A0×100%:(2)
[0090] A r is the relative enzyme activity remaining after a certain period of incubation, %; A p is the residual activity of the enzyme after a certain period of incubation; A0 is the enzyme activity without incubation; t is the incubation time, h;
[0091] From formula (1) and (2), we can get
[0092] LqCy r = - k d t (3)
[0093] The deactivation reaction rate constant k can be calculated by formula (3): d .
[0094] In summary, by substituting the data into the calculation, the half-life of the enzyme t 1 / 2 =ln2 / k d .
[0095] The investigation of the optimal temperature of the beneficial mutant cannot accurately describe the change of the thermal stability of acetaldehyde lyase. Therefore, the present invention measures the thermal stability curve of the beneficial mutant enzyme. The results are as follows: Figure 2 As shown. Figure 2It can be seen that the activities of all enzymes decreased with time, and the decrease in most beneficial mutants was slower than that in the initial mutant M1, indicating that the thermal stability of these beneficial mutants was improved. However, the enzyme activities of five mutants decreased significantly, and their thermal stability decreased, such as the thermal stability of the D39K, V181S, S183P and H185R mutants.
[0096] The thermal stability curve can only observe the trend of thermal stability changes of the initial mutant M1 and each beneficial mutant, but cannot directly reflect the changes in the thermal stability of the enzyme. The half-life of the initial mutant M1 and each beneficial mutant is calculated according to the above half-life calculation formula. The results are as follows: Figure 3 As shown. Figure 3 It can be seen that the half-life of the initial mutant is 7.5h, and the half-life of the E500R mutant is the most obvious, reaching 18.3h, which is 2.44 times the half-life of the initial mutant M1. In addition, the half-lives of the eight mutants at the three sites 89, 148 and 182 all reached more than 10h. From the calculation results of the half-life, the increase in the optimum temperature does not necessarily mean that the thermal stability will increase. The optimum temperatures of D39, V181S, S183P and H185R have all increased, but their half-lives are less than 7.5h.
[0097] 3. Determination of acetaldehyde tolerance
[0098] Take 1 mg of crude enzyme of each mutant, use high concentration acetaldehyde as substrate, concentration gradient is 1.5, 2, 2.5M, prepare 0.5mL catalytic reaction system according to the above enzyme activity determination method, shake and react at 30℃, 180rpm for 6h, determine the yield of acetoin, and calculate the conversion rate of acetaldehyde at different concentrations. The results are shown in Figure 4 .
[0099] Depend on Figure 4It can be seen that when the acetaldehyde concentration is 1.5M, the acetaldehyde conversion rate of the initial mutant M1 is 80%, among which the acetaldehyde conversion rates of A148I and S503I mutants are the highest, close to 100%, and the acetaldehyde conversion rates of D39K, R89W, R89Y, V181S, A134K, L182I and E500R mutants also reach more than 90%, indicating that the acetaldehyde tolerance of these sites has been improved to a certain extent; while the acetaldehyde conversion rates of M133L, A148V, H185R and D193M mutants are lower than that of the initial mutant M1, indicating that the acetaldehyde tolerance of these sites has decreased. When the acetaldehyde concentration was 2M, only the R89Y, A148I and V181S mutants had an acetaldehyde conversion rate of more than 90%, indicating that these three mutants had a high acetaldehyde tolerance, while the acetaldehyde tolerance of the D39K and R89W mutants dropped sharply, with an acetaldehyde conversion rate of less than 70%, indicating that these two mutants had a low tolerance at this acetaldehyde concentration. When the acetaldehyde concentration reached 2.5M, the acetaldehyde conversion rate of the initial mutant M1 was only 8%, and the other mutants all showed a significant decrease. Only the acetaldehyde conversion rate of the A148I mutant reached nearly 100%, indicating that the acetaldehyde tolerance of this mutant was greatly improved.
[0100] 3. Determination of enzyme kinetics
[0101] Take 30 μg of pure enzyme of each mutant, add acetaldehyde as substrate at different concentrations, ranging from 2 mM to 600 mM, prepare 0.5 mL of catalytic reaction system according to the above enzyme activity determination method, react at pH 8 and temperature 30 °C for 1 h, and determine the enzyme activity. K was obtained by fitting with GraphPad Prism 5 software m With V max Value, according to K cat =V max / [Enzyme], and finally the catalytic conversion number K is obtained cat and catalytic efficiency constant K cat / K m , test results see Figure 5 and Table 1.
[0102] Table 1 Enzyme kinetic parameters of the initial mutant M1 and beneficial mutants
[0103]
[0104] Depend on Figure 5 As shown in Table 1, the kinetic parameters of the mutant enzymes were improved to varying degrees compared with those of M1, among which V max The highest was 26.95 U / mg, which was 4.57 times that of M1. The K cat / K mThe highest value is 87.56s -1 ·M -1 , which is 3.33 times that of M1. Only the catalytic efficiency of D39K, R89Y, V181S, S183P and H185R mutants decreased compared with the initial mutant M1, among which the S183P mutant decreased the most, with its K cat / K m Only 21.47s -1 ·M -1 . K m The value represents the affinity of the enzyme for the substrate, among which the substrate affinity of D39K increased to 55.98mM, which is 1 / 4 of the initial mutant M1 of 202.20mM.
[0105] Example 2: First Iteration Mutation
[0106] In order to further improve the thermal stability and catalytic performance of acetaldehyde lyase, this Example 2 performs a first iterative mutation on the single point mutation in Example 1, in order to obtain an iterative mutant with better thermal stability and catalytic performance. The specific process is as follows:
[0107] 1. The mutants in Example 1 are classified according to the interface where they are located. Five of them are located at the AB interface, namely D39K, R89W, R89Y, E500R and S503I; two are located at the AC interface, namely M133L and A134K; and eight are located at the AD interface, namely A148I, A148V, V181S, L182I, L182M, S183P, H185R and D193M. Since the half-life and catalytic efficiency of the three mutants D39K, S183P and D193M are significantly reduced, and the acetaldehyde tolerance of the R89W mutant has decreased significantly, these four mutants are removed from the candidate mutation sites for iterative mutation; and A148V is also excluded because the catalytic performance of the mutant A148I at the same site is significantly higher, so the remaining 10 mutants are candidate mutants for iterative mutation. Among them, the thermal stability and catalytic efficiency of the E500R mutant located at the AB interface, the A134K mutant located at the AC interface, and the A148I mutant at the AD interface are the highest at their interfaces. Therefore, these three mutants were selected as the starting mutants for iterative mutations at each interface.
[0108] 2. In order to improve the efficiency of iterative mutation, we carried out iterative mutations on three interfaces simultaneously. The first iterative mutation of the AB interface used mutant E500R as the starting mutant, and performed site-directed mutation on position 89. The result of the mutation was R89Y, which was named iterative mutant M2; the AC interface used mutant A134K as the starting mutant, and performed site-directed mutation on position 133. The result of the mutation was M133L, which was named iterative mutant M3; the AD interface used mutant A148I, and performed site-directed mutation on position 181. The result of the mutation was V181S, which was named iterative mutant M4.
[0109] 3. The enzymatic properties and kinetic parameters of the first iteration mutants M2, M3 and M4 were measured. The measurement process was basically the same as in Example 1, as follows:
[0110] 1. Determination of optimum temperature
[0111] According to the optimum temperature determination results in Example 1, during the optimum temperature determination process, the temperature gradient of the first iteration mutant was changed to 30°C, 35°C, 40°C, 45°C, 50°C, and 55°C. The specific determination results are shown in Figure 6 .Depend on Figure 6 It can be seen that the optimum temperature of the three iterative mutants is 45°C, among which the optimum temperature of iterative mutant M4 is the most significantly improved, from 35°C of the optimum temperature of the A148I mutant to 45°C, an increase of 10°C.
[0112] 2. Thermal stability curve
[0113] In order to more accurately determine the changes in thermal stability, the incubation time was adjusted to 8 h. The activity of the enzyme decreased with time, and the decline was relatively slow. In addition, when the incubation time was extended to 8 h, it still had a higher enzyme activity, indicating that the thermal stability of the iterative mutant was improved.
[0114] 3. Half-life determination
[0115] The half-life determination process in Example 1 was used for determination. The half-life test results of the first iteration mutant were as follows: Figure 8 As shown. Figure 8 It can be seen that the iterative mutant M2 is 21.3 h, the iterative mutant M3 is 13.7 h, and the iterative mutant M4 is 18.4 h. The half-life of each iterative mutation is compared with the half-life before iterative mutation. The half-life has been significantly improved, indicating that iterative mutation can further improve the thermal stability of the mutant. According to the determination of the optimal temperature and half-life of the iterative mutants, the thermal stability of iterative mutant M4 has been improved most significantly, with the optimal temperature increased by 10°C and the half-life increased by 6.8 h.
[0116] 4. Determination of enzyme kinetics
[0117] The enzyme kinetics of the three iterative mutants were determined according to the test method in Example 1. The results are shown in Fig. 9 and Table 2.
[0118] Table 2 Kinetic parameters of mutant enzymes in the first iteration
[0119]
[0120]
[0121] Depend on Fig. 9 As shown in Table 2, compared with the enzyme kinetic parameters in Example 1, the K cat / K m The values of K cat / K m The value was improved the most, by 2.34 times, and the K cat / K m The K of iterative mutant M3 was increased by 1.67 times, indicating that the catalytic performance of iterative mutants M2 and M4 was improved. cat / K m From 45.05 s before the iterative mutation -1 ·M -1 Reduced to 31.41 s -1 ·M -1 , the catalytic performance decreased significantly, and the catalytic rate V max It decreased from 26.95 U / mg to 10.92 U / mg, indicating that the catalytic performance of the AC interface mutant decreased after the addition of the M133L mutation site.
[0122] 4. Determination of acetaldehyde tolerance
[0123] The acetaldehyde concentration gradient was modified to 2 M and 2.5 M. The specific conversion rate and change trend are shown in Fig.10 As shown. Fig.10It can be seen that when the acetaldehyde concentration is 2 M, the acetaldehyde conversion rates of iterative mutants M2 and M4 are close to 100%, especially the acetaldehyde conversion rate of iterative mutant M2 is increased from 76% before mutation to 100%, which is significantly improved. The acetaldehyde conversion rate of iterative mutant M3 is only close to 40%, which is significantly lower than the 91% acetaldehyde conversion rate before mutation, indicating that the acetaldehyde tolerance of the iterative mutant is reduced. When the acetaldehyde concentration is 2.5 M, the acetaldehyde conversion rate of iterative mutant M4 is increased to 100%, which is an improvement compared with the 95% acetaldehyde conversion rate before mutation. Based on the above acetaldehyde tolerance measurement results, the acetaldehyde tolerance of iterative mutants M2 and M4 has been improved, while the acetaldehyde tolerance of iterative mutant M3 has been significantly reduced.
[0124] In summary, the first iteration mutant of the AB interface was determined to be M2, with mutation sites E500R and R89Y, the first iteration mutant of the AD interface was determined to be M4, with mutation sites A148I and V181S, and the acetaldehyde tolerance of the first iteration mutant M3 of the AC interface decreased. Finally, it was determined that the mutation site of the AC interface was only A134K.
[0125] Example 3: Second Iteration Mutation
[0126] As can be seen from Example 2, the mutation result of the AC interface is determined to be only A134K, and the mutants located at the AC interface have completed all combinations, so the AC interface is no longer subjected to subsequent iterative mutations. The AB interface uses iterative mutant M2 as the starting mutant for the second iterative mutation, the mutation site is 503, and the result of the mutation is S503I, which is named iterative mutant M5. The AD interface uses iterative mutant M4 as the starting mutant for the second iterative mutation, the mutation site is 182, and there are two mutants located at the 182 site, namely L182M and L182I, and the one with L182M as the second iterative mutation combination is named iterative mutant M6, and the one with L182I as the second iterative mutation combination is named iterative mutant M7.
[0127] The enzymatic properties and kinetic parameters of the second iteration mutants M5, M6 and M7 were measured, and the measurement process was basically the same as in Example 2. The specific results are as follows:
[0128] 1. Determination of optimum temperature and thermal stability curve
[0129] The results of the optimal temperature and thermal stability curve of the second iteration mutant enzyme are as follows Fig.11 As shown in Figure 1, Figure A is the optimum temperature measurement result, and Figure B is the thermal stability curve. Fig.11It can be seen that the optimum temperature of the three iterative mutants is 45°C. The enzyme activities of iterative mutants M6 and M7 at the same site are quite different at the optimum temperature, and the decrease in the thermal stability curve of M6 is significantly lower than that of M7. It can be seen that the addition of the L182M mutation site has a more obvious improvement in the thermal stability of acetaldehyde lyase. Moreover, the activity of iterative mutant M6 did not decrease significantly when catalyzing the reaction at 50°C.
[0130] 2. Determination of half-life
[0131] The remaining enzyme activity data in the thermal stability curve of the second iterative mutant was substituted into the half-life calculation formula. After calculation, the half-lives of the three iterative mutants were all improved. The specific changes in the half-lives are as follows: Fig.12 As shown. Among them, the half-life of iterative mutant M6 was the highest, reaching 23.7h, which was 73% higher than the half-life of iterative mutant M4 (13.7h), while the half-life of iterative mutant M7 reached 16.8h, which was only 22.6% higher. This once again shows that the addition of the L182M mutation site can more effectively improve the thermal stability of acetaldehyde lyase. The half-life of the second iterative mutant M5 at the AB interface was calculated to be 26.6h, an increase of 24.9%.
[0132] 3. Determination of enzyme kinetic parameters
[0133] The enzyme kinetic parameters of the three iterative mutants of the second iterative mutation were measured. The results are as follows: Fig.13 And as shown in Table 3.
[0134] Table 3 Enzyme kinetic parameters of the second iteration mutants
[0135] Iteration Mutants <![CDATA[V max (U·mg -1 )]]> <![CDATA[K m (mM)]]> <![CDATA[K cat (s -1 )]]> <![CDATA[K cat / K m (s -1 ·M -1 )]]> M5 20.20±0.18 156.7±1.02 19.92 127.12 M6 32.20±0.72 191.9±0.80 31.76 165.50 M7 5.97±0.15 123.7±0.44 5.89 47.62
[0136] Depend on Fig.13 As shown in Table 3, by comparing the enzyme kinetic parameter data of the second iteration mutant and the first iteration mutant strain, the K cat / K m The K value of the iterative mutant M7 at the same site was significantly improved by 2.34 times. cat / K m The value decreased, indicating that the catalytic ability of the mutant decreased. The K cat / K m The value did not change significantly.
[0137] 4. Determination of acetaldehyde tolerance
[0138] The catalytic efficiency of the second iteration mutant crude enzyme under high acetaldehyde concentration conditions was measured. The specific conversion rate and change trend are as follows: Fig.14shown.
[0139] Depend on Fig.14 It can be seen that the acetaldehyde conversion rate of iterative mutants M5 and M7 dropped sharply under high acetaldehyde concentration conditions, and the acetaldehyde conversion rate at 2M acetaldehyde concentration was only 13.6% and 33.1%, indicating that the substrate tolerance of acetaldehyde lyase decreased significantly after iterative mutation. Moreover, the acetaldehyde conversion rate of iterative mutant M6 at 2M acetaldehyde concentration was only 88.9%, indicating that the improvement of catalytic activity is accompanied by a decrease in stability.
[0140] In summary, the second iterative mutant of the AD interface was determined to be M6, with mutation sites A148I, V181S and L182M, and the iterative mutant M5 was determined as the candidate iterative mutation site of the AB interface.
[0141] Example 4: Third Iteration Mutation
[0142] Since the acetaldehyde tolerance of the second iterative mutation has a serious downward trend, the iterative combination needs to be re-determined in the modification of the substrate tolerance of acetaldehyde lyase. The mutation sites of the second iterative mutant M5 of the AB interface are E500R, R89Y and S503I. This iterative mutation considers the combination of the E500R mutation site and the S503I site for investigation, and the iterative mutant is named M8. The third iterative mutant of the AD interface uses the iterative mutant M7 as the starting mutant, and performs site-directed mutation on the 185 site. The mutation result is H185R, and the iterative mutant is named M9. However, the acetaldehyde tolerance of the iterative mutant M6 decreases. In order to obtain an iterative mutant with higher acetaldehyde tolerance, the L182M mutation site in the iterative mutant M6 is replaced with H185R, and it is named iterative mutant M10, focusing on the changes in its acetaldehyde tolerance. The specific iterative mutation sequence is shown in Table 4:
[0143] Table 4 Iterative mutation order
[0144]
[0145] The enzymatic properties and kinetic parameters of the third iteration mutants M8, M9 and M10 were measured, and the measurement process was basically the same as in Example 2. The specific results are as follows:
[0146] 1. Determination of optimum temperature and thermal stability curve
[0147] The results of the optimal temperature and thermal stability curve of the third iteration mutant enzyme are as follows Fig.15 As shown in Figure 1, Figure A is the optimum temperature measurement result, and Figure B is the thermal stability curve. Fig.15It can be seen that the optimum temperature of the three iterative mutants is 45°C. Among them, the iterative mutant M8 located at the AB interface has an optimum temperature of 45°C, but its enzyme activity at this temperature is significantly lower, which is nearly half of that before mutation, and its thermal stability curve shows a significant downward trend. The thermal stability change trends of iterative mutants M9 and M10 are almost the same, indicating that the site H185R of the iterative mutation has a greater impact on the thermal stability of acetaldehyde lyase.
[0148] 2. Determination of half-life
[0149] The remaining enzyme activity data in the third iteration mutant thermal stability curve was substituted into the half-life calculation formula to calculate the half-life. The result is as follows: Fig.16 As shown. The half-life of M8 is only 12.2h, which is 1 / 3 lower than before mutation, indicating that the thermal stability of this iterative mutant is poor. The half-life of iterative mutant M9 is 27.3h, while the half-life of iterative mutant M10 is 20.6h. The half-life of iterative mutant M9 is higher, indicating that its thermal stability is higher than that of iterative mutant M10.
[0150] 3. Determination of enzyme kinetic parameters
[0151] The enzyme kinetic parameters of the three iterative mutants of the third iterative mutation were measured. The results are as follows: Fig.17 And as shown in Table 5.
[0152] Table 5 Kinetic parameters of the third iteration mutant enzymes
[0153] Iteration Mutants <![CDATA[V max (U·mg -1 )]]> <![CDATA[K m (mM)]]> <![CDATA[K cat (s -1 )]]> <![CDATA[K cat / K m (s -1 ·M -1 )]]> M8 15.30±0.27 758.9±2.29 15.09 19.88 M9 57.01±1.01 493.0±1.37 56.22 114.04 M10 43.31±0.98 396.3±1.22 42.71 107.77
[0154] Depend on Fig.17 As shown in Table 5, the enzyme kinetic parameters of iterative mutants M9 and M10 were significantly improved compared with those before mutation. max The value increased by nearly one-fold, indicating that the mutation site H185R of this mutation combination is the key site affecting the catalytic efficiency of acetaldehyde lyase.
[0155] 4. Determination of acetaldehyde tolerance
[0156] The catalytic efficiency of the third iteration mutant crude enzyme under high acetaldehyde concentration conditions was measured. The specific conversion rate and change trend are as follows: Fig.18 shown.
[0157] Depend on Fig.18 It can be seen that, combined with the analysis and comparison of the test results of the second iterative mutant acetaldehyde tolerance, it was found that the acetaldehyde tolerance of iterative mutant M9 decreased significantly. When the acetaldehyde concentration was 2.5M, the acetaldehyde conversion rate was only 13.8%, while its V maxIt increased to 57.01U / mg, which is 1.77 times that before the mutation. This once again shows that it is impossible to significantly improve the catalytic efficiency and substrate tolerance of the mutant at the same time. The acetaldehyde tolerance of the iterative mutant M10 decreased more significantly. The acetaldehyde tolerance of the iterative mutation M8 at the AB interface did not show a significant improvement, indicating that the combination of E500R and S503I did not have a significant effect on improving acetaldehyde tolerance.
[0158] Based on the analysis of the measurement results of the catalytic performance and thermal stability of the third iterative mutant, the iterative mutant M9, which has the most obvious improvement in the catalytic efficiency and thermal stability of acetaldehyde lyase, was determined as the third iterative mutant of the AB interface, and the mutation sites are A148I, V181S, L182M and H185R.
[0159] Example 5: Iterative mutation combination among three interfaces
[0160] The optimal iterative mutation combination belonging to each interface was obtained through three iterative mutations with the interface as the unit. The optimal iterative mutation combination of the AB interface is iterative mutant M5, with mutation sites E500R, R89Y and S503I, the optimal iterative mutation combination of the AC interface is A134K, and the optimal iterative mutation combination of the AD interface is iterative mutant M9, with mutation sites A148I, V181S, L182M and H185R. This iterative mutation is to combine these three iterative combinations again for iterative mutation, in order to obtain an iterative mutant with better catalytic performance and higher acetaldehyde tolerance.
[0161] The iterative mutant M9 of the AD interface has the best effect on improving the catalytic efficiency and thermal stability of acetaldehyde lyase. Therefore, the iterative mutant M9 of the AD interface was selected as the starting mutant for this iterative mutation. Three new iterative mutants were constructed, among which the iterative mutant M9 of the AD interface was recombined with the iterative mutant M5 of the AB interface and named M11, with mutation sites A148I, V181S, L182M, H185R, E500R, R89Y and S503I; the iterative mutant M9 of the AD interface and A134K of the AC interface were recombined and named M12, with mutation sites A148I, V181S, L182M, H185R and A134K; the iterative mutants of the three interfaces were combined together and named M13, with mutation sites A148I, V181S, L182M, H185R, E500R, R89Y, S503I and A134K.
[0162] The enzymatic properties and kinetic parameters of the third iteration mutants M11, M12 and M13 were measured, and the measurement process was basically the same as in Example 2. The specific results are as follows:
[0163] 1. Determination of optimum temperature and thermal stability
[0164] The temperature gradient of the optimum temperature determination was increased by 5°C to 35-60°C, and the time of thermal stability determination remained unchanged at 8h. The specific determination results are as follows: Fig.19 As shown. Fig.19 It can be seen that the optimum temperature of the three iterative mutants is 45°C, and their enzyme activity drops sharply at 55°C, indicating that their catalytic ability is significantly improved at high temperatures. Among them, the optimum temperature change curve and thermal stability of the iterative mutant M13 of the three interfaces are the most gentle, indicating that the mutant has a high thermal stability.
[0165] 2. Determination of half-life
[0166] Substitute the remaining enzyme activity data in the above thermal stability curve into the half-life calculation formula to calculate the half-life. The result is as follows: Fig. 20 shown.
[0167] Depend on Fig. 20 It can be seen that the half-life of iterative mutant M11 is 34.1h, the half-life of iterative mutant M12 is 27.0h, and the half-life of iterative mutant M13 is 36.3h. Compared with before mutation, the half-life of the three iterative mutants has been significantly improved, especially the iterative mutant M12, the half-life of the iterative mutant A134K at the AC interface and the iterative mutant M9 at the AD interface was recombined from 9.8h to 27.0h, an increase of nearly 3 times. Among them, the iterative mutant M13 has the highest half-life, reaching 36.3h, which is 4.84 times higher than the initial mutant M1, and 1.98 times higher than the 18.3h of the mutant E500R with the highest half-life before iterative mutation. This shows that the thermal stability of acetaldehyde lyase can be effectively improved by iterative mutation.
[0168] 3. Determination of enzyme kinetic parameters
[0169] The enzyme kinetic parameters of three iterative mutants with three interface combinations were determined. Fig.21 and as shown in Table 6.
[0170] Table 6 Enzyme kinetic parameters of three interface combination iterative mutants
[0171] Iteration Mutants <![CDATA[V max (U·mg -1 )]]> <![CDATA[K m (mM)]]> <![CDATA[K cat (s -1 )]]> <![CDATA[K cat / K m (s -1 ·M -1 )]]> M1 5.40±0.14 202.20±2.11 5.32 26.31 M11 68.74±1.03 325.10±1.28 67.79 208.52 M12 38.04±0.52 167.60±0.34 37.51 223.81 M13 78.07±1.17 267.90±0.92 76.99 287.38
[0172] Depend on Fig.21 As shown in Table 6, compared with the interface combination mutation, the V max and K cat / K m The values of all of them were significantly improved, among which the V maxand K cat / K m The value reached the highest value that can be achieved so far, increasing to 78.07U / mg and 287.38s -1 ·M -1 , which were significantly improved compared with the initial mutant M1, by 14.5 and 10.9 times, respectively, while the optimal single-point mutant V max and K cat / K m The increase in the values was only 4.99 and 3.32 times, which shows that iterative mutation combinations can further improve the catalytic ability of acetaldehyde lyase mutants.
[0173] 4. Determination of acetaldehyde tolerance
[0174] The catalytic efficiency of the three interface combination iterative mutant crude enzymes under high acetaldehyde concentration conditions was determined. The specific conversion rates and change trends are shown in Figure 2. Fig. 22 As shown. Fig. 22 It can be seen that the acetaldehyde tolerance of the iterative mutants after the three interface mutation sites were recombined was significantly improved, and the acetaldehyde conversion rate reached 100% when the acetaldehyde concentration was 2M. The acetaldehyde conversion rate of iterative mutants M12 and M13 was significantly improved when the acetaldehyde concentration was 2.5M, among which M13 had the highest acetaldehyde conversion rate, reaching 82.3%. The two iterative mutants have one thing in common, that is, after the mutations at the AC interface are combined into iterative mutants, the acetaldehyde conversion is significantly improved under high acetaldehyde concentration conditions, which shows that the addition of the A134K mutation site at the AC interface is conducive to the improvement of the acetaldehyde tolerance of the iterative mutants.
[0175] The iterative mutants of Examples 2-5 are summarized as shown in Table 7:
[0176] Table 7 Summary of iterative mutants
[0177]
[0178] Example 6: Fed-batch reaction
[0179] It can be seen from Examples 1-5 that the iterative mutant with the highest catalytic efficiency, thermal stability and acetaldehyde tolerance is M13, which has 8 mutation sites, including R89Y, A134K, A148I, V181S, L182M, H185R, E500R and S503I. During the iterative mutation process, a relatively special iterative mutant M4 also appeared, with mutation sites A148I and V181S. This iterative mutant can achieve complete conversion when the acetaldehyde concentration is 2.5M, reaching the highest acetaldehyde tolerance so far. Therefore, these mutants were subjected to batch fed reaction determination, and the specific process is as follows:
[0180] According to the measured acetaldehyde tolerance of each mutant, three gradients of acetaldehyde concentration were set for this catalytic reaction, namely 1M, 1.5M and 2M. During the catalytic reaction, the amount of acetoin generated was detected in real time. When the acetaldehyde conversion rate reached more than 90%, feeding was started, and the concentration of the feed was the same as the initial acetaldehyde concentration. The catalytic reaction was stopped when the amount of acetoin generated no longer increased. The acetaldehyde lyase used in the catalytic reaction was the crude enzyme solution after the strain was crushed, and the reaction concentration was 5 mg / mL. The specific catalytic reaction system is shown in Table 8, the acetaldehyde concentration of the feed and the feeding time are shown in Table 9, and the specific results are shown in Table 9. Fig.23 .
[0181] Table 8 Feed-batch reaction system
[0182] Components Volume / content Crude enzyme 5mg / mL Acetaldehyde 1、1.5、2M TPP 0.2mM <![CDATA[Mg 2+ ]]> 2mM 50 mM PBS buffer (pH 8.0) Up to 0.5mL
[0183] Table 9 Acetaldehyde concentration and feeding time of feed
[0184] serial number name Acetaldehyde concentration Refill time A Initial mutant M1 1.0M 4h 1.5M No feeding 2.0M No feeding B Fusion protein ELP-M1 1.0M 3h 1.5M 3h 2.0M 3h C Iteration mutant M4 1.0M 0.5h, 1.5h 1.5M 1h, 3h 2.0M 2h D Iteration mutant M13 1.0M 0.5h, 1h, 2h 1.5M 1h, 3h 2.0M 1h, 4h
[0185] Depend on Fig.23 It can be seen that after the feed reaction, the initial mutant M1 has the highest acetoin production when the acetaldehyde concentration is 2M, with a yield of 0.68M (60.67g / L). The iterative mutant M13 has the highest acetoin production after the feed reaction, and its acetoin production under the condition of acetaldehyde concentration of 2M can reach 2.13M (187.59g / L), which is 3.13 times the acetoin production of the initial mutant M1. Due to the addition of elastin-like polypeptides ELPs, the fusion protein ELP-M1 has improved the acetaldehyde tolerance of the fusion protein, so that the acetoin production reached 1.09M (95.75g / L) when the acetaldehyde concentration was 2M, which is 1.58 times higher than that of the initial mutant M1. The acetoin production of the iterative mutant M4 with the highest acetaldehyde tolerance reached the highest level when the acetaldehyde concentration was 1.5M, and the acetoin production was 1.80M (158.02g / L), which was 2.65 times the acetoin production of the initial mutant M1, and lower than that of the iterative mutant M13 with three interface combination mutations. Based on the comprehensive enzymatic properties and the measurement data of the fed-batch reaction, the iterative mutant M13 has the highest catalytic efficiency and thermal stability among all mutants, has a high acetaldehyde tolerance, and has the highest acetoin production after the fed-batch reaction at a concentration of 2M acetaldehyde, indicating that the mutant M13 obtained by iterative mutation has a high industrialization potential.
[0186] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. An acetaldehyde lyase having thermal stability and substrate tolerance, characterized in that The acetaldehyde lyase ALS-I28V / L482E was mutated as follows: The mutation site is M133L; or The mutation site is A134K; or The mutation site is E500R; or The mutation site is R89Y; or The mutation site is A148I; or The mutation site is A148V; or The mutation site is L182I; or The mutation site is L182M; or Iterative mutation M2: combined mutation of E500R and R89Y mutation sites; or Iterative mutation M4: combined mutation of A148I and V181S mutation sites; or Iterative mutation M5: combined mutation of E500R, R89Y and S503I mutation sites; or Iterative mutation M6: combined mutation of A148I, V181S and L182M mutation sites; or Iterative mutation M9: A148I, V181S, L182M and H185R mutation site combination mutation; or Iterative mutation M10: combined mutation of A148I, V181S and H185R mutation sites; or Iterative mutation M11: E500R, R89Y, S503I, A148I, V181S, L182M and H185R mutation site combination mutation; or Iterative mutation M12: A134K, A148I, V181S, L182M and H185R mutation site combination mutation; or Iterative mutation M13: combined mutations of E500R, R89Y, S503I, A134K, A148I, V181S, L182M and H185R mutation sites.
2. Use of the thermostable and substrate-tolerant acetaldehyde lyase according to claim 1 in catalyzing the preparation of acetoin from acetaldehyde.
3. A method for preparing acetoin by catalyzing acetaldehyde with the acetaldehyde lyase having thermal stability and substrate tolerance as claimed in claim 1, characterized in that: The following steps are involved: Acetaldehyde lyase is added to acetaldehyde to catalyze the reaction and prepare acetoin.
4. The method according to claim 3, characterized in that The acetaldehyde concentration is 1-2.5M.
5. The method according to claim 3 or 4, characterized in that: The molar ratio of acetaldehyde to acetaldehyde lyase is 1:3-8×10 -6 .
6. The method according to claim 3, characterized in that The temperature during the catalytic reaction is 30-60°C and the reaction time is 1-4h.
7. The method according to claim 3, characterized in that A buffer solution is also added to the reaction system, and the pH of the buffer solution is 6-8.
8. The method according to claim 3, characterized in that The reaction system also includes coenzyme at a concentration of 0.15-0.25 mM.
9. The method according to claim 3, characterized in that: The reaction system also includes metal ions, and the concentration of the metal ions is 1.5-2.5 mM.
Citation Information
Patent Citations
Acetaldehyde lyase, acetaldehyde lyase fusion protein as well as preparation method and application of acetaldehyde lyase and acetaldehyde lyase fusion protein
CN115838714A
